Paper C 2019 Ironing device

Here a quick first answer to the paper.

So far only two of our C tutors (Joeri Beetz and me) have made the paper, so we may make some amendments tomorrow when more tutors will have made it.

Priority: valid for claims 1-5; invalid for claims 6 and 7 (claims and supporting paragraphs [17] and [18] respectively were not present in the priority application).

Evidence list: A2, A4, A5, A6: 54(2) for all claims (one option in claim 1 gets no date).
 A3 is 54(2) for claims 6 and 7; not useable for claims 1-5 (US application, not useable under 54(3))

Claims 1 is an and/or claim and covers three embodiments.
Claim 1 has been amended after filing: 'or' has been changed to 'and/or'. This introduces a third option: the 'and' embodiment KeraMa and KeraSi layer. This embodiment is not derivable from A1 as filed (the two options are only mentioned separately in A1 [16] and filed claim 1). Thus, perform an attack on this embodiment under Art.100(c), 123(2). No date is assigned to this embodiment and no further attack performed.

Claim 1 Kerama: lack of novelty in view of A4 first test.

Claim 1: KeraSi: lack of inventive step in view A4 first test + A4 second test

Claim 2(1) [limited to Kerama]: Inv. step A2 + A4 first test

Claim 3(2) [limited to Kerama]: Inv. step A2 + A4 first test. Basically same attack as claim 2. Is a product-by-process claim. Process not shown, but same product

Claim 4(ind): Inv. step A6 +A2

Claim 5(4): Inv. step A6 + A2 + A5

Claim 6(4): Nov. A3

Claim 7(6): Inv. Step A3 + A6

Looking forward to your comments.

Jelle Hoekstra

C 2019: first impressions?

To all who sat the C-paper today:

What are your first impressions to this year's C-paper? Any general or specific comments?

How did this year's C-paper compare to the C papers of 2013 - 2018 (assuming your practiced those)?

Any pleasant and/or unpleasant surprises?

The paper and our answers

The C paper is available in all three languages from the EQE website, Compendium, Paper C.

We will give (the core of) our answer after we have received the paper, made the paper, and completion of our internal review. See here.

We look forward to your comments!

Comments are welcome in any official EPO language, not just English. So, comments in German and French are also very welcome!
Please do not post your comments anonymously - it is allowed, but it makes responding more difficult and rather clumsy ("Dear Mr/Mrs/Ms Anonymous of 03-03-2018 03:03"), whereas using your real name or a pseudonym is more personal, more interesting and makes a more attractive conversation. You do not need to log in or make an account - it is OK to just put your (nick) name at the end of your post.